Skip to main content
Clinical Trials/NCT00487097
NCT00487097CompletedNot Applicable

Effect of EPA, GLA and Antioxidants on the Immune Response - Cellular and Molecular Mechanisms of Wound Healing in Critically Ill Patients.

Rabin Medical Center1 site in 1 country40 target enrollmentStarted: September 1, 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Improvement of wound healing of pressure sores

Study Overview

Brief Summary

The purpose of this study is to investigate whether the addition of omega-3 and antioxidants to nutritional support in critically ill patients in the intensive care unit influences the immune and anti-inflammatory systems and so improves wound healing.

Detailed Description

A prospective randomized study to include 40 consecutive patients admitted to the general intensive care unit. The control group will receive nutritional support composed of a standard formula. The study group will receive nutritional support enriched with fish oil and anti-oxidants. The following variables will be assessed in all patients: demographics, severity of illness, assessment of bed sores. Blood tests will also be taken for the following: CD 8, CD 14, CD 18, CD 11a, CD49c, CD 49d. In addition, blood samples will be collected for TNF, IL-1b, IL-6, IL-8, and levels of C-reactive protein. Metabolic parameters such as resting energy expenditure, BMI, albumin, prealbumin, levels of zinc, relationship between omega 3 and omega 6. Theses test will be performed at time of ICU admission, days 7, 14 and 28 after admission.

The outcome: improved repair of pressure sores, together with improvement in objective parameters of immunity and inflammation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Critically ill patients in intensive care unit
  • •Grade 2 pressure sores

Exclusion Criteria

  • •Immunosuppression with steroids or other agents
  • •Active bleeding
  • •Head trauma

Arms & Interventions

Study Group

Experimental

Enteral Nutrition with Omega 3 (Eicosapentanoic acid, docosahexaenoic acid)

Intervention: Eicosapentanoic acid, docosahexaenoic acid (Dietary Supplement)

Control Group

No Intervention

Patients in control group will receive nutritional support composed of a standard formula

Outcomes

Primary Outcomes

Improvement of wound healing of pressure sores

Time Frame: within 28 days

Secondary Outcomes

  • Improvement in parameters of immunity and inflammation(Within 28 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pierre singer

Professor, MD

Rabin Medical Center

Study Sites (1)

Loading locations...

Similar Trials

The Effect of Antioxidants on the Immune... | Clinical Trial